Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.

New FDA draft guidance for drugmakers focuses on trial design for developing obesity treatments. Read more here.

Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 478.78% and ...

I had been taking Zepbound for about six months when it clicked. My period — the monster that turned me from a functioning ...